Nanoparticles and nanostructured carriers for drug delivery and contrast enhancement

Currently, nanotechnologies are widely used in science and industry. It is known that the application of drug delivery nanostructured carriers for biomedicine is one of the promising areas of nanotechnology. Nanostructured carriers can be used in the diagnosis process for detecting a neoplastic tumor cells in peripheral blood, for contrast enhancement on magnetic resonance imaging (MRI), as well as for targeted drug delivery to tumor tissues. Agents for the targeted delivery (nanoparticles, liposomes, microcapsules, and etc) can affect the healthy tissues and organs, cause side effects and have a toxic effect. Therefore, it necessary to study the morphological changes that occur not only in the "target", such as a tumor, but also the internal organs, taking place under the influence of both the agents for targeted drug delivery and physical impact induced remote controlled drug release. Thus , the aim of our work is selection of the most promising agents for targeted drug delivery to tumor and contrast agents for in vivo visualization of tumor tissue boundaries , as well as their impact on the organs and tissues as results of nanostructured object biodistribution.

[1]  S. Loening,et al.  Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia , 2001 .

[2]  Everett E. Carpenter,et al.  Gold-coated iron (Fe@Au) nanoparticles: Synthesis, characterization, and magnetic field-induced self-assembly , 2001 .

[3]  D. S. Letbetter,et al.  Surface-immobilized dextran limits cell adhesion and spreading. , 2000, Biomaterials.

[4]  Changyou Gao,et al.  Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[5]  O. Kuznetsov,et al.  Ferro-Carbon Particles , 1997 .

[6]  R Weissleder,et al.  Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[7]  Michiya Matsusaki,et al.  Enzyme-responsive release of encapsulated proteins from biodegradable hollow capsules. , 2006, Biomacromolecules.

[8]  Gleb B. Sukhorukov,et al.  Urease encapsulation in nanoorganized microshells. , 2001 .

[9]  C T Hung,et al.  Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats. , 1990, Life sciences.

[10]  A. Curtis,et al.  Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. , 2003, Biomaterials.

[11]  Ji-Hun Yu,et al.  STRUCTURE AND MAGNETIC PROPERTIES OF SiO 2 COATED Fe 2 O 3 NANOPARTICLES SYNTHESIZED BY CHEMICAL VAPOR CONDENSATION PROCESS , 2003 .

[12]  A. M. Prodan,et al.  Iron oxide magnetic nanoparticles: characterization and toxicity evaluation by in vitro and in vivo assays , 2013 .

[13]  Gleb B. Sukhorukov,et al.  Intracellularly Degradable Polyelectrolyte Microcapsules , 2006 .

[14]  Jun Yoshida,et al.  Preparation of Tumor-Specific Magnetoliposomes and Their Application for Hyperthermia , 2001 .

[15]  Shanta Raj Bhattarai,et al.  N-Acylated chitosan stabilized iron oxide nanoparticles as a novel nano-matrix and ceramic modification , 2007 .

[16]  Michael D. Kaminski,et al.  Detoxification of blood using injectable magnetic nanospheres: A conceptual technology description , 2005 .

[17]  R Weissleder,et al.  Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.

[18]  John Webb,et al.  Formation of spherical iron(III) oxyhydroxide nanoparticles sterically stabilized by chitosan in aqueous solutions. , 2003, Journal of inorganic biochemistry.

[19]  Jun Yoshida,et al.  Targeting Hyperthermia for Renal Cell Carcinoma Using Human MN Antigenspecific Magnetoliposomes , 2001, Japanese journal of cancer research : Gann.

[20]  L. Trahms,et al.  Drug loaded magnetic nanoparticles for cancer therapy , 2006 .

[21]  Urs O. Häfeli,et al.  Scientific and clinical applications of magnetic carriers , 1997 .

[22]  J Lawry,et al.  Monitoring tumour cells in the peripheral blood of small cell lung cancer patients. , 2002, Cytometry.

[23]  Ranjita Shegokar,et al.  Present status of nanoparticle research for treatment of tuberculosis. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[24]  Kostas Kostarelos,et al.  Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. , 2007, Nanomedicine.

[25]  Dinesh S. Kommireddy,et al.  pH Responsive Decomposable Layer-by-Layer Nanofilms and Capsules on the Basis of Tannic Acid , 2005 .

[26]  E. Kim,et al.  Biomedical applications of superparamagnetic iron oxide nanoparticles encapsulated within chitosan , 2007 .

[27]  Hiroyuki Honda,et al.  Medical application of functionalized magnetic nanoparticles. , 2005, Journal of bioscience and bioengineering.

[28]  Gary Friedman,et al.  Magnetic targeting for site-specific drug delivery: applications and clinical potential. , 2009, Expert opinion on drug delivery.

[29]  Wolfgang J Parak,et al.  Multifunctionalized polymer microcapsules: novel tools for biological and pharmacological applications. , 2007, Small.

[30]  P K Gupta,et al.  Drug targeting in cancer chemotherapy: a clinical perspective. , 1990, Journal of pharmaceutical sciences.

[31]  Nikita A. Navolokin,et al.  Morphological changes in the kidney, liver and spleen during prolonged administration of iron nanoparticles , 2012 .

[32]  Heike Pohla,et al.  Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. , 2003, The Journal of urology.

[33]  Gleb B. Sukhorukov,et al.  Influence of Shell Structure on Stability, Integrity, and Mesh Size of Polyelectrolyte Capsules: Mechanism and Strategy for Improved Preparation , 2005 .

[34]  M. de Cuyper,et al.  Magnetoliposomes , 1988, European Biophysics Journal.

[35]  Helmuth Möhwald,et al.  Redox-controlled molecular permeability of composite-wall microcapsules , 2006, Nature materials.

[36]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[37]  Yujun Wang,et al.  In situ preparation of magnetic chitosan/Fe3O4 composite nanoparticles in tiny pools of water-in-oil microemulsion , 2006 .

[38]  J. Schlenoff,et al.  Polyelectrolyte Multilayers Containing a Weak Polyacid: Construction and Deconstruction , 2001 .

[39]  Wolfgang J. Parak,et al.  Uptake of Colloidal Polyelectrolyte‐Coated Particles and Polyelectrolyte Multilayer Capsules by Living Cells , 2008 .

[40]  H Honda,et al.  Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles. , 1996, Noshuyo byori = Brain tumor pathology.

[41]  Christian Bergemann,et al.  Physiological aspects in magnetic drug-targeting , 1999 .

[42]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[43]  Peter Wust,et al.  Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. , 2007, European urology.

[44]  Paul Mulvaney,et al.  Silica encapsulation of quantum dots and metal clusters , 2000 .

[45]  Nikita A. Navolokin,et al.  Synthesis of magnetite hydrosols and assessment of their impact on living systems at the cellular and tissue levels using MRI and morphological investigation , 2013, Nanotechnologies in Russia.

[46]  F. Pelegrini,et al.  Biodistribution and biocompatibility investigation in magnetoliposome treated mice , 2004 .

[47]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[49]  I. Lucet,et al.  Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.

[50]  Frank Caruso,et al.  Probing the permeability of polyelectrolyte multilayer capsules via a molecular beacon approach. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[51]  Robert N. Muller,et al.  Influence of the length of the coating molecules on the nuclear magnetic relaxivity of superparamagnetic colloids , 2004 .

[52]  R. Perdrisot,et al.  Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: contribution of microencapsulation to improved biodistribution. , 1989, Magnetic resonance imaging.

[53]  James F. Rusling,et al.  Direct Electrochemistry of Myoglobin and Cytochrome P450cam in Alternate Layer-by-Layer Films with DNA and Other Polyions , 1998 .

[54]  Wim E. Hennink,et al.  In vivo Cellular Uptake, Degradation, and Biocompatibility of Polyelectrolyte Microcapsules† , 2007 .

[55]  S. S. Bansode,et al.  MICROENCAPSULATION: A REVIEW , 2022, International Research Journal of Modernization in Engineering Technology and Science.

[56]  Hiroyuki Honda,et al.  Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. , 2003, Journal of bioscience and bioengineering.

[57]  V V Zuev,et al.  Liposomes loaded with hydrophilic magnetite nanoparticles: Preparation and application as contrast agents for magnetic resonance imaging. , 2015, Colloids and surfaces. B, Biointerfaces.

[58]  J. Santamaría,et al.  Magnetic nanoparticles for drug delivery , 2007 .

[59]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[60]  G. Sukhorukov,et al.  Cytotoxicity of nanoparticle-loaded polymer capsules. , 2005, Talanta.

[61]  Dorothy Farrell,et al.  Gold-coated iron nanoparticles for biomedical applications , 2003 .

[62]  S. Soenen,et al.  Magnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine. , 2009, Nanomedicine.

[63]  Edson Amaro,et al.  Biocompatible superparamagnetic iron oxide nanoparticles used for contrast agents: a structural and magnetic study , 2005 .

[64]  V. N. Naumenko,et al.  Dispersity of magnetite in magnetic liquids and the interaction with a surfactant , 1990 .

[65]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[66]  Gleb B. Sukhorukov,et al.  Influence of different salts on micro-sized polyelectrolyte hollow capsules , 2005 .

[67]  P. Morais,et al.  Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. , 2001, Biophysical journal.

[68]  Frank de Vocht,et al.  Static magnetic field effects on human subjects related to magnetic resonance imaging systems. , 2005, Progress in biophysics and molecular biology.

[69]  U. Bakowsky,et al.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.

[70]  P Reichardt,et al.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.

[71]  Changyou Gao,et al.  Layered microcapsules for daunorubicin loading and release as well as in vitro and in vivo studies , 2008 .

[72]  Y. S. Tarahovsky.  “Smart” liposomal nanocontainers in biology and medicine , 2010, Biochemistry (Moscow).

[73]  Etienne Duguet,et al.  A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran , 2005 .

[74]  Claire Wilhelm,et al.  The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells. , 2008, Biomaterials.

[75]  J M Collins,et al.  Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  V A Namiot,et al.  Magnetoliposomes: another principle of cell sorting. , 1983, Biochimica et biophysica acta.

[77]  Mark D Pagel,et al.  A review of responsive MRI contrast agents: 2005-2014. , 2015, Contrast media & molecular imaging.

[78]  C T Hung,et al.  Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats. , 1990, Journal of microencapsulation.